AIDS Therapies

Epimmune Provides HIV Vaccine Program Update

Published in AIDS Weekly, October 8th, 2001

Epimmune Inc., presenting at the AIDS Vaccine 2001 Conference held in Philadelphia, Pennsylvania, September 7, 2001, provided additional information on its HIV vaccine program including its initial vaccine candidate and clinical trial plans.

Epimmune anticipates that it will file an Investigational New Drug (IND) application for its initial vaccine candidate, a therapeutic HIV vaccine, in the first quarter of 2002. Clinical trials could begin approximately one month later, pending FDA review. They stated that a pre-IND meeting was previously held in August 2001 with U.S. Food and Drug Administration (FDA) staff and representatives of the U.S. National Institutes of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-10-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry